And on and on
How can decision-makers justify promoting the mammoth undertaking of annual influenza vaccination when the best-quality evidence base is near empty?
This was the first question we left you with in the previous post.
In 2008, we examined several policy documents written by influential organisations from WHO, the UK, the US, Germany, Australia and Canada. The power brokers of influenza prevention created compelling policy arguments for vaccination. For example, the WHO estimated that “vaccination of th…